(In the Media)Round-table Discussion; Pharmaceutical Industry in 2020 Part 1: The Time to Act is Now: People’s talk of the Friction Between Promotion of New Drug Development and its Policies (Monthly Mix, the September, 2016 edition)
date : 9/1/2016
An article featuring a “Round-table Discussion; Pharmaceutical Industry in 2020 Part 1: The Time to Act is Now: People’s talk of the Friction Between Promotion of New Drug Development and its Policies”, in which Toshio Miyata HGPI board member participated, appeared in the September issue of Monthly Mix.
In the midst of new drug development to support the fundamentals of pharmaceutical industries, ways drug discovery should be handled has become an urgent issue for corporations.
Proposals were made on how pharmaceutical industries should be expanded in the next 5 years , and what should become of it in 2020.
Katsufumi Jo ( Director of General Affairs Division, Ministry of Health, Labour and Welfare)
Isao Teshirogi (Representative Director, SHionogi & Co., LTD)
Toshio Miyata (HGPI Board Member)
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-11-05
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 7: Where We’ve Been and Where We’re Going: Lessons from Pandemic Response” (December 18, 2026)
-
2026-11-13
[Discussion Points] Addressing AMR Measures for an Era of Healthy Longevity: Ensuring Safety and Security for Older Adults in a Super-Aged Society (October 23, 2026)



